NICE backs PredictImmune’s IBD prognosis test
The CE-marked prognostic test for guiding treatment options uses a gene expression “signature”.
Read More
Tag: PredictSURE IBD
Innovate UK grant for PredictImmune’s IBD drug response test
Innovate UK has awarded PredictImmune a £100,000 grant to apply its biomarker-based technology towards the prediction of drug response in IBD.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
